Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 22 , ISSUE 5 ( 2018 ) > List of Articles


Primary cutaneous mucormycosis in a trauma patient with morel-lavallée lesion

Nidhi Bhatia, Tanvir Samra

Keywords : Amphotericin B, Morel-Lavallée lesions, primary cutaneous mucormycosis

Citation Information : Bhatia N, Samra T. Primary cutaneous mucormycosis in a trauma patient with morel-lavallée lesion. Indian J Crit Care Med 2018; 22 (5):375-377.

DOI: 10.4103/ijccm.IJCCM_343_17

License: CC BY-ND 3.0

Published Online: 01-02-2015

Copyright Statement:  Copyright © 2018; The Author(s).


Mucormycosis is an aggressive fungal infection caused by zygomycetes from the order of Mucorales. Immunocompromised patients or patients with comorbidities are susceptible to this infection. There are many forms of mucormycosis such as rhino-orbito-cerebral, cutaneous, gastrointestinal, and pulmonary. Cutaneous mucormycosis is rare in trauma patients with no comorbidities. Morel-Lavallée lesions are rare degloving injuries in trauma patients. We report a case of cutaneous mucormycosis in a trauma patient with the Morel-Lavallée lesions.

PDF Share
  1. Holtom PD, Obuch AB, Ahlmann ER, Shepherd LE, Patzakis MJ. Mucormycosis of the tibia: A case report and review of the literature. Clin Orthop Relat Res 2000;381:222-8.
  2. Kwon-Chung J, Bennett JE. Mucormycosis. In: Medical mycology. Philadelphia, Pa: Lea & Febiger; 1992. p. 524-59.
  3. Ribes JA, Vanover-Sams CL, Baker J. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301.
  4. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: A review of the clinical manifestations, diagnostic and treatment. Clin Microbiol Infect 2004;10:31-47.
  5. Weinberg JM, Baxt RD, Egan CL, Rook AH, Atillasoy ES, Ragsdale BD. Mucormycosis in a patient with acquired immunodeficiency syndrome. Arch Dermatol 1997;133:249-51.
  6. Carpenter CF, Subramanian AK. Images in clinical medicine. Cutaneous zygomycosis (mucormycosis). N Engl J Med 1999;34:1891.
  7. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al. The third International Consensus Definition of septic shock(Sepsis-3). JAMA 2016;315:801-810.
  8. Cocanour CS, Miller-Crotchett P, Lawrence Reed R Johnson OC, Fisher RP. Mucormycosis in trauma patients. J trauma 1992;32:3-5.
  9. Meyer RD, Armstrong D. Mucormycosis-changing states. CRC Crit Rev Clin Lab Sci. 1973;4:421.
  10. Bruck HM, Nash G, Foley FD, Pruitt BA Jr. Opportunistic fungal infection of the burn wound with phycomycetes and aspergillus. Arch Surg 1971;102:476-82.
  11. Everett ED, Pearson S, Rogers W. rhizopus surgical wound infection assosciated with elasticized adhesive tape dressing. Arch surg 1979;114:738-9.
  12. Dennis JE, Rhodes KH, Cooney DR. Nosocomial Rhizopus infection (zygomycosis) in children. J Pediatr 1980;96:824-8.
  13. Sugar AM. Agents of mucormycosis and related species. In: Mandell GI, Bennett JE, Dolin R, Mandell, Douglas and Bennett's Principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier; 2006.
  14. Chakrabarti A, Kumar P, Padhe AA, Chatha L, Singh SK, Das A et al. Primary cutaneous zygomycosis due to Saksenaea vasiformis and Apophysomyces elegans. Clin Infect Dis 1997;24:580-3.
  15. Kordy FN, Al-Mohsen IZ, Hashem F, Almodovar E, Al Hajjar S, Walsh TJ. Successful treatment of a child with posttraumatic necrotizing fasciitis caused by Apophysomyces elegans: case report and review of literature. Pediatr Infect Dis J 2004;23:877-9.
  16. Adam RD, Hunter G, DiTomasso J, Comerci G. Mucormycosis: Emerging prominence of cutaneous infection. Clin Infect Dis 1994;19:67-76.
  17. George Petrikkos, Anna Skiada, Olivier Lortholary, Emmanuel Roilides, Thomas J. Walsh, Dimitrios P. Kontoyiannis; Epidemiology and Clinical Manifestations of Mucormycosis, Clinical Infectious Diseases, Volume 54, Issue suppl_1, 1 February 2012, p. S23-S34.
  18. Keys RF, Halderson AM, Rhodes KH. Nosocomial outbreak of rhizopus infections assosciated with Elastoplast dressings-Minnesota. MMWR 1978;27:33-4.
  19. Kobayashi M, Hiruma M, Matsushita A, Kawai M, Ogawa H, Udagawa Set. Cutaneous zygomycosis: A case report and review of Japanese reports. Mycoses 2001;44:311-5.
  20. Okhuysen PC, Rex JH, Kapusta M, Fife C. Successful treatment of extensive post traumatic soft tissue and renal infection due to Apophysomycetes elegant. Clin Infect Dis 1994;19:329-31.
  21. Seguin P, Musellec H, Le Gall F, Chevrier S, Le bouquin V, Malledant Y. Post traumatic course complicated by cutaneous infection with Absidia corymbifera. Eur J Clin Microbiol Infect Dis 1999;18:737-9.
  22. Tobon AM, Arango M, Fernandez D, Restrapo A. Mucormycosis(zygomycosis) in a heart- kidney transplant recipient. Recovery after posaconazole. Clin Infect Dis 2003;36:1488-91.
  23. McAllister TA, Stark JM. Inhibitory effects of hyperbaric oxygen in bacteria and fungi. Lancet 1963;2:1040.
  24. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005;41:634-53.
  25. Skiada A, Rigopoulos D, Larios G, Petrikkos G, Katsambas A. Global epidemiology of cutaneous zygomycosis. Clin Dermatol 2012;30:628-32.
  26. Skiada A, Petrikkos G. Cutaneous zygomycosis. Clin Microbiol Infect 2009;15:41-5.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.